Dr. Steven Dowdy is a Professor of Cellular & Molecular Medicine at UCSD School of Medicine.
In 1994, Dr. Dowdy became an Investigator of the Howard Hughes Medical Institute and an Assistant Professor at Washington University School of Medicine. He moved his lab to UCSD in 2001. Beyond his early work on G1 cell cycle control in cancer, his research over the last 30 years has primarily focused on delivery of macromolecular therapeutics, including siRNAs, ASOs, peptides and proteins, and developing new chemistry to tackle the rate-limiting endosomal escape problem. Dr. Dowdy has been advising biotech and pharmaceutical companies for 35 years, and currently sits on five biotech Science Advisory Boards. He was an elected board member of the Oligonucleotide Therapeutics Society (OTS) and remains on the OTS advisory board.
He received his Ph.D. in molecular genetics from the University of California Irvine and was a postdoctoral fellow at the Whitehead Institute, MIT.